Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00SFN
|
|||
| Former ID |
DIB006378
|
|||
| Drug Name |
TUCARESOL
|
|||
| Synonyms |
BW-A589C; Tucaresol < Rec INN; 4-(2-Formyl-3-hydroxyphenoxymethyl)benzoic acid; 589C; 589C80
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Immune System disease [ICD-11: 4A01-4B41; ICD-10: C00-C97] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H12O5
|
|||
| Canonical SMILES |
C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O
|
|||
| InChI |
1S/C15H12O5/c16-8-12-13(17)2-1-3-14(12)20-9-10-4-6-11(7-5-10)15(18)19/h1-8,17H,9H2,(H,18,19)
|
|||
| InChIKey |
XEDONBRPTABQFB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 84290-27-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00343941) Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.